Cargando…
Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
Prostate cancer is the second deadliest cancer in the US and the fourth most common cancer among Saudi males. Patients usually present with non-metastatic disease and treated with localized therapy. However, up to 40% of the patients will experience biochemical recurrence, within 10 years. Androgen...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438706/ https://www.ncbi.nlm.nih.gov/pubmed/30976180 http://dx.doi.org/10.1016/j.jsps.2018.12.005 |